Randomized phase III study for the treatment of advanced indolent non-Hodgkin's lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab.

Source:http://linkedlifedata.com/resource/pubmed/id/12601483

Download in:

View as

General Info

PMID
12601483